{"id":"pneumococcal-23v-polysaccharide-vaccine","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Injection site pain"},{"rate":"10-20%","effect":"Fatigue"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Fever"},{"rate":"5-10%","effect":"Malaise"}]},"_chembl":{"chemblId":"CHEMBL2109142","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The pneumococcal 23v polysaccharide vaccine contains 23 different capsular polysaccharides from Streptococcus pneumoniae. These polysaccharides are used to stimulate the body's immune response, which then produces antibodies to fight off pneumococcal infections.","oneSentence":"This vaccine stimulates the body's immune response to produce antibodies against pneumococcal serotypes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:29:14.499Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of invasive pneumococcal disease caused by Streptococcus pneumoniae serotypes included in the vaccine"}]},"trialDetails":[{"nctId":"NCT00560950","phase":"PHASE3","title":"Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2007-07","conditions":"Pneumococcal Infection","enrollment":143}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["V110","PNEUMOVAX"],"phase":"phase_3","status":"active","brandName":"pneumococcal 23v polysaccharide vaccine","genericName":"pneumococcal 23v polysaccharide vaccine","companyName":"Merck Sharp & Dohme LLC","companyId":"merck","modality":"Biologic","firstApprovalDate":"","aiSummary":"This vaccine stimulates the body's immune response to produce antibodies against pneumococcal serotypes. Used for Prevention of invasive pneumococcal disease caused by Streptococcus pneumoniae serotypes included in the vaccine.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}